ð é«åžçç
ð äžé éé»
- è: Leptospira interrogans (pathogenic) + non-pathogenic L. biflexa â spirochete with hooked ends, å sharply (corkscrew)
- Reservoir: åç© renal tubules (rats, cattle, dogs, pigs); shed in urine into water/soil
- Transmission: ç®è / é»è / çµè / é£ / åæ°Ž contact with contaminated water/soil
- Risk: èŸ²æ¥ (rice/sugarcane farmers), abattoir, sewer workers, military, 颱颚 / 措氎 outbreaks, æ¶å€éå (triathletes), æ°ŽäžæŽ»å (kayaking, swimming)
- 2 phase èšåº:
- Phase 1 (Leptospiremic, 1-7d): æ¥ fever, é ç, myalgia (calf!), conjunctival suffusion, nausea, abdominal pain
- Brief defervescence 1-3d
- Phase 2 (Immune, 4-30d): meningitis (aseptic), uveitis, severe forms
- Severe (10% â âWeilâs diseaseâ):
- Jaundice (cholestatic) + AKI + åºè¡ (pulmonary hemorrhage)
- Pulmonary hemorrhage syndrome (SPHS) â Taiwan/Asia variant
- Myocarditis, arrhythmia
- Mortality 5-15%
- Dx:
- MAT (microscopic agglutination test) â gold standard, paired serology
- PCR of blood (early), urine (later)
- IgM ELISA rapid
- Dark-field microscopy â historical
- Treatment:
- Mild: doxycycline 100 PO bid à 7d OR azithromycin
- Severe: ceftriaxone 1-2 g IV qd à 7d OR PCN G 1.5 M U IV q6h à 7d
- Supportive: ICU, dialysis, ventilator, transfusion
- Prevention: Doxycycline 200 mg PO weekly for high-risk exposure (military, agricultural, flood relief workers); avoid contaminated water
1ïžâ£ 现èåž
- Leptospira â spirochete with hooked / question-mark shape
- Motile (axial filaments)
- Aerobic, dark-field visible (rare in routine)
- 250+ serovars in 25+ serogroups; pathogenic in L. interrogans
- Common serovars:
- Icterohaemorrhagiae â Weilâs classic
- Canicola â dogs
- Hardjo â cattle
- Pomona â pigs
- Australis, Autumnalis â varied
- Reservoir hosts: rodents (rat #1), domestic livestock, dogs (canicola), wild animals
- Animal asymptomatic carriers â chronic shed urine
- Survival in warm fresh water weeks-months â explains outbreak after floods
2ïžâ£ æµè¡ç
åž
- Global ~ 1 million severe cases/yr, 60,000 deaths
- Tropical / subtropical: SE Asia, India, Caribbean, Pacific
- Outbreaks after: 颱颚, 措氎, æµ·å¯, hurricane
- Taiwan: é¢±é¢šåŸ surge (Morakot 2009, etc.)
- USA: Hawaii dominant, also continental sporadic
- 2024: ongoing 颱颚 / climate change increasing risk
- High-risk occupations: rice farmer, abattoir worker, sewer worker, military deployment, veterinarian, water sports
- 2010s emerging issue: urban outbreaks in çŽçŽ / Baltimore from rat-contaminated water
3ïžâ£ èšåºè¡šçŸ (Biphasic Classic)
Phase 1: Leptospiremic / Septicemic (Days 1-7)
- æ¥æ§ onset, é«ç, severe headache, myalgia (especially calves + back) â classic
- Conjunctival suffusion (redness without exudate â diagnostic clue)
- Nausea, vomiting, abdominal pain
- Pharyngitis, cough
- Lymphadenopathy
- Self-limited if mild
Brief Defervescence (Days 5-7)
- 1-3 day improvement
- Many recover here without further illness
Phase 2: Immune (Days 7-30+)
- Recurrence of fever (lower grade)
- Aseptic meningitis (mononuclear CSF)
- Uveitis (anterior, posterior, panuveitis)
- Hepatitis (icteric)
- Renal involvement
- Hemorrhage
Severe Disease (âWeilâs Diseaseâ)
- 5-10% of all cases
- Triad: jaundice (cholestatic hyperbilirubinemia) + AKI + bleeding
- Severe hepatic involvement (bilirubin > 20 mg/dL, modest ALT/AST)
- AKI: ATN + interstitial nephritis, hypokalemia (early, distal tubular dysfunction)
- Bleeding: skin petechiae, GI bleed, alveolar hemorrhage, retinal
- Severe Pulmonary Hemorrhage Syndrome (SPHS) â Taiwan + Asia variant; alveolar hemorrhage + ARDS + high mortality 50%+
- Myocarditis (T-wave changes, AVB)
- Mortality 5-15% overall, higher with SPHS
4ïžâ£ 蚺æ·
A. Serology
- MAT (Microscopic Agglutination Test) â gold standard, paired sera (acute + convalescent)
- 4-fold rise or single high titer (1:800+)
- Slow (specialty labs)
- IgM ELISA â rapid, 確蚺 days 5-10 onwards
- Rapid tests (LFA / lateral flow) â point of care, sensitivity varies
B. Molecular
- PCR of blood â high yield first 7-10 days (leptospiremic phase)
- PCR of urine â days 10-30 (immune phase shed urine)
- PCR CSF â meningitis form
C. Dark-Field Microscopy
- Blood (early), CSF, urine (late) â sensitivity low, lab capability rare
- Historical method
D. Culture
- Blood, CSF, urine
- Specialized media (EMJH, Fletcherâs)
- Slow (4-6 wk) â not for clinical decision
E. Lab Findings
- WBC â or normal, neutrophilic
- Thrombocytopenia
- â CK (myalgia)
- â AST/ALT (modest, often < 200)
- â Bilirubin (severe, often disproportional to LFT)
- BUN/Cr â
- Hypokalemia (distal tubular)
- CSF: lymphocytic pleocytosis, normal glucose, mild protein â
5ïžâ£ æ²»ç
Mild Disease (Outpatient)
- Doxycycline 100 mg PO bid à 7d
- Alt: azithromycin 500 mg day 1 â 250 qd à 4d
- Amoxicillin (less data)
Severe Disease (ICU)
- Ceftriaxone 1-2 g IV qd à 7d
- OR PCN G 1.5 M U IV q6h à 7d
- OR Doxycycline 100 mg IV q12h à 7d (alt)
- OR Cefotaxime 1 g IV q6h à 7d
- å antibiotic efficacy (PCN, doxy, ceftriaxone same outcome in multiple RCTs)
- Add steroid for SPHS â controversial; some RCTs show benefit in pulmonary hemorrhage
Supportive
- ICU monitoring
- Dialysis if AKI
- Mechanical ventilation if SPHS / ARDS
- Transfusion for bleeding
- Vasopressor for shock
- Plasma exchange â some advocate severe SPHS
Jarisch-Herxheimer Reaction
- Can occur after PCN dose
- Less common than syphilis
Pregnancy
- Doxycycline contraindicated
- PCN G or ceftriaxone preferred
Pediatric
- Ceftriaxone or PCN
- Doxycycline avoided < 8 yr (or short course OK)
6ïžâ£ Prevention
Personal
- Avoid contaminated water (especially after flood)
- Protective gear (boots, gloves) for high-risk work
- Wound care after exposure
- Boil / treat water
Doxy-PEP Chemoprophylaxis
- Doxycycline 200 mg PO weekly during high-risk exposure period
- Military, flood relief workers, athletes in endemic
- Pre-exposure or post-exposure (within 48 hr)
Vaccination
- Animals: routine in dogs (4 serovars), livestock
- Human: limited (some countries use serovar-specific killed vaccine â China, Japan, France for high-risk workers)
- Not US-available
Public Health
- Rodent control
- Sanitation
- Flood response messaging
- éå ± (notifiable in most countries)